{"entity":{"type":"insider","cik":"0001702031","url":"/insider/0001702031","json_url":"/insider/0001702031.json","name":"Birznieks Gunther","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":11,"first":"2018-01-04","last":"2026-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Birznieks Gunther","source":"filing","n_filings":11,"first_seen":"2018-01-04","last_seen":"2026-03-04"}],"transactions":[{"id":6003549,"accession":"0001702031-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001702031-26-000002","line_url":"/filing/0001702031-26-000002#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42431.0,"shares_display":"42,431","price_per_share":8.2659,"price_display":"8.27","price_state":"stated","total_value":350730.4029,"total_display":"350,730.40","total_whole":"350,730","shares_owned_after":494197.0,"shares_owned_after_display":"494,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":2674716,"accession":"0000950170-24-027249","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-027249","line_url":"/filing/0000950170-24-027249#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8684.0,"shares_display":"8,684","price_per_share":4.1322,"price_display":"4.13","price_state":"stated","total_value":35884.0248,"total_display":"35,884.02","total_whole":"35,884","shares_owned_after":313569.0,"shares_owned_after_display":"313,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider"},{"id":2674711,"accession":"0000950170-24-027249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-027249","line_url":"/filing/0000950170-24-027249#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8727.0,"shares_display":"8,727","price_per_share":4.2964,"price_display":"4.30","price_state":"stated","total_value":37494.6828,"total_display":"37,494.68","total_whole":"37,495","shares_owned_after":322253.0,"shares_owned_after_display":"322,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider"},{"id":8326405,"accession":"0001209191-23-016460","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-016460","line_url":"/filing/0001209191-23-016460#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8268.0,"shares_display":"8,268","price_per_share":6.264,"price_display":"6.26","price_state":"stated","total_value":51790.752,"total_display":"51,790.75","total_whole":"51,791","shares_owned_after":205980.0,"shares_owned_after_display":"205,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-06","scope":"insider"},{"id":8326400,"accession":"0001209191-23-016460","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016460","line_url":"/filing/0001209191-23-016460#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8509.0,"shares_display":"8,509","price_per_share":6.2044,"price_display":"6.20","price_state":"stated","total_value":52793.2396,"total_display":"52,793.24","total_whole":"52,793","shares_owned_after":214248.0,"shares_owned_after_display":"214,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"},{"id":6389037,"accession":"0001209191-22-015154","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-015154","line_url":"/filing/0001209191-22-015154#line-3","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11517.0,"shares_display":"11,517","price_per_share":11.2696,"price_display":"11.27","price_state":"stated","total_value":129791.9832,"total_display":"129,791.98","total_whole":"129,792","shares_owned_after":188807.0,"shares_owned_after_display":"188,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-02","scope":"insider"},{"id":6389035,"accession":"0001209191-22-015154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-015154","line_url":"/filing/0001209191-22-015154#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4084.0,"shares_display":"4,084","price_per_share":11.19,"price_display":"11.19","price_state":"stated","total_value":45699.96,"total_display":"45,699.96","total_whole":"45,700","shares_owned_after":200324.0,"shares_owned_after_display":"200,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-02","scope":"insider"},{"id":5036831,"accession":"0001209191-21-017272","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-017272","line_url":"/filing/0001209191-21-017272#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16620.0,"shares_display":"16,620","price_per_share":18.1873,"price_display":"18.19","price_state":"stated","total_value":302272.926,"total_display":"302,272.93","total_whole":"302,273","shares_owned_after":171708.0,"shares_owned_after_display":"171,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-03","scope":"insider"},{"id":5036826,"accession":"0001209191-21-017272","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-017272","line_url":"/filing/0001209191-21-017272#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3845.0,"shares_display":"3,845","price_per_share":18.659,"price_display":"18.66","price_state":"stated","total_value":71743.855,"total_display":"71,743.86","total_whole":"71,744","shares_owned_after":188328.0,"shares_owned_after_display":"188,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":2178034,"accession":"0001209191-20-016197","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-016197","line_url":"/filing/0001209191-20-016197#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5535.0,"shares_display":"5,535","price_per_share":10.6566,"price_display":"10.66","price_state":"stated","total_value":58984.281,"total_display":"58,984.28","total_whole":"58,984","shares_owned_after":159473.0,"shares_owned_after_display":"159,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-04","scope":"insider"},{"id":2178030,"accession":"0001209191-20-016197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-016197","line_url":"/filing/0001209191-20-016197#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12223.0,"shares_display":"12,223","price_per_share":10.0373,"price_display":"10.04","price_state":"stated","total_value":122685.9179,"total_display":"122,685.92","total_whole":"122,686","shares_owned_after":165008.0,"shares_owned_after_display":"165,008","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider"},{"id":2432797,"accession":"0001209191-20-002027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-002027","line_url":"/filing/0001209191-20-002027#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4020.0,"shares_display":"4,020","price_per_share":15.9257,"price_display":"15.93","price_state":"stated","total_value":64021.314,"total_display":"64,021.31","total_whole":"64,021","shares_owned_after":147231.0,"shares_owned_after_display":"147,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-06","scope":"insider"},{"id":8023756,"accession":"0001209191-19-015731","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-015731","line_url":"/filing/0001209191-19-015731#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8788.0,"shares_display":"8,788","price_per_share":19.887,"price_display":"19.89","price_state":"stated","total_value":174766.956,"total_display":"174,766.96","total_whole":"174,767","shares_owned_after":151251.0,"shares_owned_after_display":"151,251","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-04","scope":"insider"},{"id":8023753,"accession":"0001209191-19-015731","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-015731","line_url":"/filing/0001209191-19-015731#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3741.0,"shares_display":"3,741","price_per_share":20.135,"price_display":"20.14","price_state":"stated","total_value":75325.035,"total_display":"75,325.04","total_whole":"75,325","shares_owned_after":160039.0,"shares_owned_after_display":"160,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-04","scope":"insider"},{"id":8188819,"accession":"0001209191-19-001994","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-001994","line_url":"/filing/0001209191-19-001994#line-3","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1619.0,"shares_display":"1,619","price_per_share":26.085,"price_display":"26.08","price_state":"stated","total_value":42231.615,"total_display":"42,231.62","total_whole":"42,232","shares_owned_after":133780.0,"shares_owned_after_display":"133,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-03","filed_date":"2019-01-04","scope":"insider"},{"id":8188813,"accession":"0001209191-19-001994","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-001994","line_url":"/filing/0001209191-19-001994","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4442.0,"shares_display":"4,442","price_per_share":26.469679873930662,"price_display":"26.47","price_state":"stated","total_value":117578.318,"total_display":"117,578.32","total_whole":"117,578","shares_owned_after":136569.0,"shares_owned_after_display":"136,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-04","scope":"insider","n_lines":2},{"id":6145191,"accession":"0001209191-18-015872","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-015872","line_url":"/filing/0001209191-18-015872#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8525.0,"shares_display":"8,525","price_per_share":18.722,"price_display":"18.72","price_state":"stated","total_value":159605.05,"total_display":"159,605.05","total_whole":"159,605","shares_owned_after":139841.0,"shares_owned_after_display":"139,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-02","scope":"insider"},{"id":6349446,"accession":"0001209191-18-002050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-002050","line_url":"/filing/0001209191-18-002050#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001702031","owner_name":"Birznieks Gunther","owner_display_name":"Birznieks Gunther","owner_url":"/insider/0001702031","role":"Officer (SVP, Business Development)","role_mark":"O","role_mark_label":"Officer (SVP, Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8568.0,"shares_display":"8,568","price_per_share":15.2634,"price_display":"15.26","price_state":"stated","total_value":130776.8112,"total_display":"130,776.81","total_whole":"130,777","shares_owned_after":118366.0,"shares_owned_after_display":"118,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001347178","name":"Vanda Pharmaceuticals Inc.","url":"/issuer/0001347178","role":"Officer (SVP, Business Development)","n_filings":11,"first_seen":"2018-01-04","last_seen":"2026-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001702031","retrieved_at":"2026-08-25T23:23:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}